| Abstrakt: |
In the ecosystem of the health system, it is very sensitive and necessary for people's health to ensure quality control, safety and effectiveness of drugs. After the Covid-19 pandemic, counterfeit vaccine and drugs are circulating and seriously threatening public health around the world. This situation needs to pay more attention to the quality and more effective safety of medicine with the aim of combating drug counterfeiting. The current measures are not effective and sufficient to deal with all the problems associated with counterfeit drugs. In this Article, by analysing the importance of drug safety monitoring, it was observed that developing countries do not have adequate and standard regulatory rules to evaluate drugs quality and safety and finally due to lack of control over the supply chain, drugs will easily enter the flow of counterfeit and fraud. It is nessessory to exist powrful and spervisor institutions in according to standards of national or international rules, as well as the applying of deterrent punishments in each stage of drug production, distribution and delivery cycle. This Research is based on the analytical-descriptive method and authentic library documents and sources. The theoretical framework of the Research is rights based on justice. [ABSTRACT FROM AUTHOR] |
